A clinical trial of Covaxin's 3rd dose will start soon in Delhi AIIMC. Principal Investigator Dr Sanjay Roy explained the need for the process in conversation with ABP News.
Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million.
Have a look at the video to know more
Bharat Biotech on Thursday announced the quick ramp up of additional manufacturing capacities for Covid-19 vaccine Covaxin by an additional 200 million.
Have a look at the video to know more
- Category
- Asia
- Tags
- Coronavirus Vaccine, Covaxin, Covaxin Trial
Sign in or sign up to post comments.
Be the first to comment